The Estee Lauder Companies has lowered its full-year guidance to account for store closures, canceled travel plans and other effects of the coronavirus outbreak. The firm achieved record-setting 16% organic growth in the second quarter, led by China, travel retail and skin care, and is confident that it can get quickly back to speed once markets recover from the global health scare.
[Estee Lauder Companies Inc.] expects a “very challenging” couple of quarters ahead as the world responds to the coronavirus outbreak in China.
During a 6 February call to discuss Lauder’s fiscal 2020 second-quarter results, company leadership declined to provide granular Q3 guidance...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
